SE7416195L - Forfarande for framstellning av cefalosporiner. - Google Patents
Forfarande for framstellning av cefalosporiner.Info
- Publication number
- SE7416195L SE7416195L SE7416195A SE7416195A SE7416195L SE 7416195 L SE7416195 L SE 7416195L SE 7416195 A SE7416195 A SE 7416195A SE 7416195 A SE7416195 A SE 7416195A SE 7416195 L SE7416195 L SE 7416195L
- Authority
- SE
- Sweden
- Prior art keywords
- cephalosporins
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB59517/73A GB1496757A (en) | 1973-12-21 | 1973-12-21 | Cephalosporin derivatives |
GB4300574 | 1974-10-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE7416195L true SE7416195L (sv) | 1975-09-22 |
Family
ID=26265028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7416195A SE7416195L (sv) | 1973-12-21 | 1974-12-20 | Forfarande for framstellning av cefalosporiner. |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5844675B2 (nl) |
AT (1) | AT344888B (nl) |
CH (1) | CH617703A5 (nl) |
DE (1) | DE2460537C2 (nl) |
DK (1) | DK674674A (nl) |
ES (2) | ES433226A1 (nl) |
FI (1) | FI65258C (nl) |
FR (1) | FR2255076B1 (nl) |
HU (1) | HU172234B (nl) |
IE (1) | IE42144B1 (nl) |
IL (1) | IL46302A (nl) |
LU (1) | LU71550A1 (nl) |
NL (1) | NL7416665A (nl) |
NO (1) | NO744621L (nl) |
SE (1) | SE7416195L (nl) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4144392A (en) | 1973-12-21 | 1979-03-13 | Glaxo Laboratories Limited | Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile |
US4095021A (en) | 1973-12-21 | 1978-06-13 | Glaxo Laboratories Limited | 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof |
GB1555471A (en) * | 1975-06-19 | 1979-11-14 | Glaxo Lab Ltd | 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof |
CA1093549A (en) * | 1976-02-16 | 1981-01-13 | Michael Gregson | Cephalosporin antibiotics |
US4165430A (en) | 1976-03-19 | 1979-08-21 | Glaxo Laboratories Limited | Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group |
US4304770A (en) | 1976-04-12 | 1981-12-08 | Fujisawa Pharmaceutical Co., Ltd. | Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof |
US4278670A (en) * | 1976-07-12 | 1981-07-14 | Smithkline Corporation | 7-Alpha-oxyiminoacylcephalosporins |
US4066762A (en) * | 1976-07-12 | 1978-01-03 | Smithkline Corporation | Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid |
GB1591439A (en) | 1976-10-01 | 1981-06-24 | Glaxo Operations Ltd | 7-syn (oxyimino -acylamido) cephalosporins |
GB1596278A (en) | 1976-11-30 | 1981-08-26 | Glaxo Operations Ltd | 7-(-oxyimino-acetamino)cephalosporin derivatives |
PH17188A (en) | 1977-03-14 | 1984-06-14 | Fujisawa Pharmaceutical Co | New cephem and cepham compounds and their pharmaceutical compositions and method of use |
SE439312B (sv) * | 1977-03-25 | 1985-06-10 | Roussel Uclaf | Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra |
ES485440A1 (es) * | 1978-10-27 | 1980-07-01 | Glaxo Group Ltd | Un procedimiento para la preparacion de antibioticos de ce- falosporina |
FR2457296A1 (fr) * | 1979-05-23 | 1980-12-19 | Rhone Poulenc Ind | Nouveaux derives de vinyl-3 cephalosporines et leur preparation |
FR2552432B2 (fr) * | 1983-09-27 | 1985-10-25 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 2-amino thiazol- 4-yl acetique, procede de preparation |
US20040166434A1 (en) | 2003-02-21 | 2004-08-26 | Dammel Ralph R. | Photoresist composition for deep ultraviolet lithography |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3641021A (en) * | 1969-04-18 | 1972-02-08 | Lilly Co Eli | 3 7-(ring-substituted) cephalosporin compounds |
GB1348985A (en) * | 1970-06-16 | 1974-03-27 | Merck & Co Inc | Esters of cephalosporin compounds |
GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
-
1974
- 1974-12-20 NO NO744621A patent/NO744621L/no unknown
- 1974-12-20 CH CH1708674A patent/CH617703A5/de not_active IP Right Cessation
- 1974-12-20 LU LU71550A patent/LU71550A1/xx unknown
- 1974-12-20 ES ES433226A patent/ES433226A1/es not_active Expired
- 1974-12-20 HU HU74GA00001174A patent/HU172234B/hu unknown
- 1974-12-20 DK DK674674A patent/DK674674A/da unknown
- 1974-12-20 IE IE2639/74A patent/IE42144B1/en unknown
- 1974-12-20 FI FI3713/74A patent/FI65258C/fi active
- 1974-12-20 NL NL7416665A patent/NL7416665A/nl not_active Application Discontinuation
- 1974-12-20 DE DE2460537A patent/DE2460537C2/de not_active Expired
- 1974-12-20 JP JP49147519A patent/JPS5844675B2/ja not_active Expired
- 1974-12-20 SE SE7416195A patent/SE7416195L/xx unknown
- 1974-12-20 AT AT1020174A patent/AT344888B/de not_active IP Right Cessation
- 1974-12-20 IL IL46302A patent/IL46302A/xx unknown
- 1974-12-23 FR FR7442541A patent/FR2255076B1/fr not_active Expired
-
1976
- 1976-09-16 ES ES451604A patent/ES451604A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FI371374A (nl) | 1975-06-22 |
IL46302A (en) | 1978-09-29 |
NO744621L (nl) | 1975-07-21 |
AU7673574A (en) | 1976-06-24 |
DE2460537C2 (de) | 1987-01-22 |
ES433226A1 (es) | 1977-07-01 |
ES451604A1 (es) | 1977-12-16 |
ATA1020174A (de) | 1977-12-15 |
FR2255076A1 (nl) | 1975-07-18 |
FR2255076B1 (nl) | 1978-11-10 |
IE42144B1 (en) | 1980-06-18 |
FI65258C (fi) | 1984-04-10 |
IE42144L (en) | 1975-06-21 |
JPS50105689A (nl) | 1975-08-20 |
NL7416665A (nl) | 1975-06-24 |
FI65258B (fi) | 1983-12-30 |
LU71550A1 (nl) | 1976-04-13 |
HU172234B (hu) | 1978-07-28 |
DK674674A (nl) | 1975-09-08 |
JPS5844675B2 (ja) | 1983-10-04 |
IL46302A0 (en) | 1975-03-13 |
CH617703A5 (en) | 1980-06-13 |
DE2460537A1 (de) | 1975-07-03 |
AT344888B (de) | 1978-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE423631B (sv) | Forfarande for framstellning av oxaalhyl-dialkylxantiner | |
NO145273C (no) | N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere | |
SE7710599L (sv) | Forfarande for framstellning av bensisoxazoler | |
SE7416195L (sv) | Forfarande for framstellning av cefalosporiner. | |
SE411212B (sv) | Forfarande for framstellning av 3-halogen-cefalosporiner | |
SE420604B (sv) | Forfarande for framstellning av oxazolderivat | |
NO147916C (no) | Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser. | |
RO70474A (ro) | PROCEDEU PENTRU PREPARAREA PARAXILENULёI | |
NO143531C (no) | Fremgangsmaate for fremstilling av acylerte benzoksazolinon-derivater. | |
NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
SE7712151L (sv) | Forfarande for framstellning av linkomycinderivat | |
SE417601B (sv) | Forfarande for framstellning av amidinokarbamider | |
NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
NO153806C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin. | |
SE417319B (sv) | Analogiforfarande for framstellning av ergopeptiner | |
TR17584A (tr) | Herbisid triazinlerinin hazirlanmasina mahsus usul | |
SE409716B (sv) | Analogiforfarande for framstellning av 11beta-alkyl-delta4-estrener | |
SE431451B (sv) | Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner | |
SE409994B (sv) | Forfarande for framstellning av amidinokarbamider | |
SE411211B (sv) | Forfarande for framstellning av 3-halogencefalosporiner | |
SE7613500L (sv) | Forfarande for framstellning av cefemderivat | |
SE401835B (sv) | Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on | |
NO141851C (no) | Fremgangsmaate for fremstilling av metyl-3-(2-kinoksalinylmetylen)-karbazat-n1.n4-dioksyd. | |
SE401506B (sv) | Forfarande for framstellning av bifenylyletrar | |
SE7508844L (sv) | Forfarande for framstellning av cefalosporiner. |